Who owns Madrigal Pharmaceuticals (MDGL)? Superinvestor holders
5 superinvestors of the 157 tracked here hold Madrigal Pharmaceuticals (MDGL) in their latest 13F filing, with $2.3B between them. John Paulson gives it the most weight: 27.9% of the reported portfolio. In their latest reported quarter, Brandon Haley opened a position; Julian and Felix Baker and Ken Griffin added; John Paulson reduced.
Ron Baron sold out of it in their latest quarter.
Key facts
- Superinvestors holding it
- 5 of 157
- Biggest holder
- Julian and Felix Baker, $1.2B
- Largest weight
- John Paulson, 27.9%of their portfolio
- Combined value
- $2.3B
- Bought last quarter
- 3
- Sold last quarter
- 2
From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.
| # | Investor | Share of their portfolio | Value | Shares | Last quarter | Shares moved | Quarter |
|---|---|---|---|---|---|---|---|
| 1 | John PaulsonPaulson & Co. | 27.9% | $719.5M | 1.34M | ▼ Reduced 3.8% | −52.21K | Q2 2026 |
| 2 | Julian and Felix BakerBaker Bros. Advisors | 5.77% | $1.2B | 2.14M | ▲ Added 0.07% | +1.5K | Q2 2026 |
| 3 | Brandon HaleyHolocene Advisors | 0.19% | $82.1M | 152.92K | New | +152.92K | Q2 2026 |
| 4 | Takis SparaggisAlkeon Capital Management | 0.17% | $40.3M | 80K | No change | 0 | Q3 2026 |
| 5 | Ken GriffinCitadel Advisors | 0.16% | $272.4M | 507.23K | ▲ Added 12% | +53.37K | Q2 2026 |
Sold out last quarter
- Ron Baronwas $2.4M · Q3 2026
Quarter by quarter
| Quarter | Filings in | Holders | Combined shares | Combined value | Bought | Sold |
|---|---|---|---|---|---|---|
| Q3 2026 | 92 | 1 | 80K | $40.3M | 0 | 1 |
| Q2 2026 | 157 | 5 | 4.22M | $2.3B | 3 | 2 |
| Q1 2026 | 157 | 6 | 4.3M | $2.2B | 2 | 3 |
| Q4 2025 | 157 | 5 | 4.12M | $2.4B | 1 | 2 |
| Q3 2025 | 157 | 5 | 4.2M | $1.9B | 3 | 1 |
| Q2 2025 | 157 | 3 | 4.07M | $1.2B | 1 | 2 |
| Q1 2025 | 156 | 4 | 4.47M | $1.5B | 2 | 0 |
| Q4 2024 | 156 | 3 | 4.02M | $1.2B | 0 | 0 |
A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.
Each holder's shares
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Takis Sparaggis | 80K | 80K | 80K | 240K | 120K | — | — | — |
| Julian and Felix Baker | · | 2.14M | 2.14M | 2.14M | 2.14M | 1.98M | 1.97M | 1.97M |
| John Paulson | · | 1.34M | 1.39M | 1.71M | 1.91M | 2.09M | 2.1M | 2.04M |
| Ken Griffin | · | 507.23K | 453.84K | — | — | — | — | — |
| Brandon Haley | · | 152.92K | — | — | — | — | 390.55K | — |
| Steve Cohen | · | — | 225.51K | — | — | — | — | — |
| Andrew Spokes | — | — | 3.32K | 3.32K | 3.32K | 3.32K | 3.32K | 3.32K |
| Robert Pitts | · | — | — | 26.85K | 29.8K | — | — | — |
A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.
Questions and answers
Which superinvestors own MDGL?
In their latest 13F filings: John Paulson (27.9% of the portfolio, $719.5M), Julian and Felix Baker (5.77% of the portfolio, $1.2B), Brandon Haley (0.19% of the portfolio, $82.1M), Takis Sparaggis (0.17% of the portfolio, $40.3M), Ken Griffin (0.16% of the portfolio, $272.4M).
Who bought MDGL last quarter?
Julian and Felix Baker (added 0.1%), Brandon Haley (new position), Ken Griffin (added 12%). “Last quarter” is each investor's latest reported quarter.
Who sold MDGL last quarter?
Reduced: John Paulson (3.8% fewer shares). Sold out entirely: Ron Baron (was $2.4M).
How current is this?
It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.
Learn
Cite this page
Funkfolio, “Who owns Madrigal Pharmaceuticals (MDGL)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/MDGL/superinvestors
Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.
Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to MDGL by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.